Robert Deans PhD

Dr. Deans is CTO at BlueRock Therapeutics. Dr. Deans has more than 25 years of experience in adult stem cell therapeutics including both hematopoietic as well as mesenchymal stem cell populations. He most recently served as Exec VP at Athersys, and prior to that was VP of Research at Osiris Therapeutics. Dr. Deans was previously a Director of R & D at Baxter. He holds degrees from MIT and the University of Michigan, with postdoctoral training at UCLA.